Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevation Oncology Inc (NQ: ELEV )

2.640 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.640
Bid (Size) 2.640 (1)
Ask (Size) 2.820 (3)
Prev. Close 2.640
Today's Range 2.640 - 2.640
52wk Range 0.3630 - 5.830
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins. 
Via Benzinga
7 Top Stocks to Buy for Under $10: May 2024
By diversifying your portfolio with top stocks for under $10, you can profit from companies that are just starting their growth stories. 
Via InvestorPlace

Performance

YTD
+319.71%
+319.71%
1 Month
+3.13%
+3.13%
3 Month
-34.81%
-34.81%
6 Month
-6.38%
-6.38%
1 Year
+84.62%
+84.62%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Recap: Elevation Oncology Q4 Earnings
Via Benzinga
How Is The Market Feeling About Elevation Oncology?
Via Benzinga
7 Top Stocks Under $7
Via InvestorPlace
5 Healthcare Stocks to Buy for 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023
Via InvestorPlace
Trim the Fat: 3 Overbought Stocks Poised for a Pullback
Via InvestorPlace
3 Stock Winners That Are Up 400% or More in 2024
Via InvestorPlace
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL
Via AB Newswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
Via FinancialNewsMedia
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
From FN Media Group LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
What's Going On With Elevation Oncology Stock?
Via Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.